找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Interventional and Endovascular Therapy of the Nervous System; A Practical Guide Pearse Morris Book 2002 Springer Science+Business Media Ne

[復(fù)制鏈接]
樓主: 照相機(jī)
31#
發(fā)表于 2025-3-26 23:15:51 | 只看該作者
32#
發(fā)表于 2025-3-27 03:24:35 | 只看該作者
Thrombolysis and Treatment of Acute Stroke,rsible brain injury probably begins about 5 minutes after onset of complete global ischemia, which does not allow much scope for completely effective therapy.. However, degrees of ischemia and vascular occlusion are variable in symptomatic patients, which means that some stroke patients can be helpe
33#
發(fā)表于 2025-3-27 06:51:19 | 只看該作者
Venous Thrombotic Disease, protein C, protein S, and factor V Leiden, or an increase in anticardiolipin A antibodies may be identified in patients with this disorder, but a precise pathogenesis may not be identifiable in 25% to 35% of patients.. The disease is frequently overlooked clinically and on CT imaging, in part due t
34#
發(fā)表于 2025-3-27 09:43:23 | 只看該作者
35#
發(fā)表于 2025-3-27 16:35:11 | 只看該作者
Extracranial Carotid and Vertebral Angioplasty and Stenting,making this also the first report of carotid PTA with distal protection. In 1980 again Sundt et al. reported the first successful transluminal angioplasties of basilar artery stenoses through intraoperative exposures..
36#
發(fā)表于 2025-3-27 21:42:59 | 只看該作者
Intracranial Angioplasty and Stenting,s aspirin in the treatment of intracranial stenosis indicates a slightly greater efficacy from warfarin in symptomatic patients. Rates of major vascular events of 8.4% (stroke 3.6%) with warfarin and 18.1% (stroke 10.4%) per year with aspirin were seen.? Evidence supporting a slightly greater effica
37#
發(fā)表于 2025-3-28 00:38:24 | 只看該作者
38#
發(fā)表于 2025-3-28 05:58:45 | 只看該作者
39#
發(fā)表于 2025-3-28 08:51:37 | 只看該作者
40#
發(fā)表于 2025-3-28 11:39:38 | 只看該作者
Pearse Morris MDder Wahrheit über die Gewalt. Die Folgen mussten das Ansehen der kommunistischen Ideologie erschüttern. Es hatte sich herausgestellt, dass zwischen der angeblic978-94-010-3691-7978-94-010-3690-0Series ISSN 0561-2551
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 16:55
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
阿城市| 洛扎县| 麻江县| 凤阳县| 浙江省| 普兰店市| 合江县| 建阳市| 临西县| 三穗县| 汤原县| 宣化县| 镇康县| 和林格尔县| 色达县| 泰顺县| 东至县| 施甸县| 博野县| 门头沟区| 孝感市| 墨江| 银川市| 临江市| 宁强县| 乡宁县| 栖霞市| 个旧市| 金阳县| 玉屏| 元朗区| 鸡西市| 洞口县| 丹巴县| 蓝山县| 惠东县| 永顺县| 浏阳市| 咸丰县| 恩施市| 山西省|